Sitagliptin may not control blood sugar during bypass surgery in diabetics: Study Medha Baranwal30 Dec 2020 11:30 AM ISTUSA: Perioperative administration of sitagliptin in diabetes patients undergoing bypass surgery does not prevent hyperglycemia or complications, finds...
Oral semaglutide leads to weight loss by improving eating control in diabetics: Study Medha Baranwal18 Dec 2020 11:15 AM ISTDenmark: Patients with type 2 diabetes (T2D) taking oral semaglutide for 12 weeks had lower energy intake resulting in reduced body fat mass,...
Dapagliflozin effectively reduces blood sugar and weight in type 1 diabetes: Study Medha Baranwal11 Nov 2020 11:15 AM ISTDelhi: A recent study evaluating dapagliflozin for the treatment of patients with type 1 diabetes (T1D) has yielded positive results. According to the...
CPAP helps lower blood sugar in diabetics with sleep apnea: Study Medha Baranwal9 Nov 2020 7:15 AM ISTChina: Patients with type 2 diabetes (T2D) and sleep apnea when treated with CPAP experience improved insulin resistance and blood sugar control,...
Gliclazide modified release better second-line treatment than sitagliptin for type 2 diabetes patients on Metformin- Study Hina Zahid9 Oct 2020 9:44 AM ISTUK: Gliclazide modified release (MR) is more effective in reducing blood sugar levels than sitagliptin in type 2 diabetes (T2D) patients already...
AI can successfully predict ESRD in diabetes patients, finds study Medha Baranwal10 Sept 2020 8:00 PM ISTNetherlands: A machine-learning model can help in the successful prediction of end‐stage renal disease (ESRD) in patients with nephropathy and type 2...
DPP-4 inhibitors use not linked to pneumonia in diabetics, says study Medha Baranwal28 July 2020 8:03 PM ISTItaly: The use of dipeptidyl-peptidase 4 inhibitors (DPP-4i) in people with type 2 diabetes is safe with regard to pneumonia risk, a recent study...
Type 2 diabetes: Semaglutide significantly reduces blood sugar and body weight Medha Baranwal16 July 2020 11:00 AM ISTCanada: Initiation of semaglutide therapy in type 2 diabetes (T2D) patients naive to GLP-1 RA therapy helped in a significant reduction of...
